My watch list
my.bionity.com  
Login  

Novartis Research Foundation

Klybeckstrasse 141
4002 Basel
Switzerland
Tel.
+41 61 696 23 00
Fax
+41 61 696 23 33

www.novartisfoundation.org
More about Novartis
  • News

    Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe

    Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe. Sandoz CEO Richard Saynor said: “This plan is a g ... more

    Novartis to invest $75 million in start-up Poseida

    Poseida Therapeutics Inc. announced closing of a Series C financing round, raising $142 million led by a $75 million equity investment from Novartis Pharma AG, and joined by several new investors including Aisling Capital Management, Pentwater Capital Management, Perceptive Advisors as well ... more

    Novartis announces change in Sandoz leadership

    Novartis announced that Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis on March 31, 2019. Francesco Balestrieri, currently Region Head Europe, Sandoz, has been appointed ad-interim CEO Sandoz. He will repor ... more

  • Companies

    Novartis Austria GmbH

    We want to find new ways to help people achieve a better and longer life. Strong values ​​define our corporate culture. They help us to implement the Novartis strategy in accordance with our mission.Our strategy is to achieve the best possible results for patients through science-based inno ... more

    Novartis Deutschland GmbH

    We want to find new ways to help people achieve a better and longer life. more

    Novartis Pharma GmbH

    We want to find new ways to help people achieve a better and longer life. more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE